New Targeted Therapy for Bone Fractures Developed

New drug for treating bone fractures has been developed. The drug, dasatinib-aspartate10-conjugate (DAC) when injected intravenously, specifically targets the fracture site and accelerates the healing process.

Related Links

CONSULT ONLINE WITH A DOCTOR